Ryman Healthcare Limited Stock Profit Margin
| RH7 Stock | EUR 2.49 0.01 0.40% |
Ryman Healthcare Limited fundamentals help investors to digest information that contributes to Ryman Healthcare's financial success or failures. It also enables traders to predict the movement of Ryman Stock. The fundamental analysis module provides a way to measure Ryman Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ryman Healthcare stock.
Ryman |
Ryman Healthcare Limited Company Profit Margin Analysis
Ryman Healthcare's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ryman Healthcare Profit Margin | 1.13 % |
Most of Ryman Healthcare's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ryman Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Ryman Healthcare Limited has a Profit Margin of 1.132%. This is 110.1% lower than that of the Healthcare sector and 112.62% lower than that of the Long-Term Care Facilities industry. The profit margin for all Germany stocks is 189.13% lower than that of the firm.
Ryman Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.Ryman Healthcare is currently under evaluation in profit margin category among its peers.
Ryman Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.82 B | |||
| Shares Outstanding | 530.46 M | |||
| Shares Owned By Insiders | 11.54 % | |||
| Shares Owned By Institutions | 16.69 % | |||
| Price To Earning | 15.33 X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 3.46 X | |||
| Revenue | 503.76 M | |||
| Gross Profit | 42.52 M | |||
| EBITDA | 788.44 M | |||
| Net Income | 692.87 M | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 61.60 % | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | 7.26 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 0.66 X | |||
| Price To Earnings To Growth | 2.57 X | |||
| Number Of Employees | 6.8 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 1.99 B | |||
| Total Asset | 10.97 B | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 10.97 B | |||
| Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Stock
Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.